Showing results (71-80 of 469) with videos related to

Sort By:
Pageof 47
Pharmacoeconomics|October 28, 1999
Cost effectiveness of riluzole in amyotrophic lateral sclerosis. Italian Cooperative Group for the Study of Meta-Analysis and the Osservatorio SIFO sui FarmaciA Messori, S Trippoli, P Becagli, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide+methotrexate+fluorouracil in patients with node-positive breast cancerA Messori, P Becagli, S Trippoli, et al.
Anti-Cancer Drugs|December 29, 2000
Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrolA Messori, F Cattel, S Trippoli, et al.
Acta Europaea Fertilitatis|March 1, 1986
Cervical cap homologous artificial insemination (AIH): the University of Florence experienceI Noci, E Chelo, G Scarselli, et al.
Acta Neurologica Scandinavica|August 17, 2006
Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?G Zaccara, A Messori, M Cincotta, et al.
Neuroradiology|October 28, 2003
Is haemosiderin visible indefinitely on gradient-echo MRI following traumatic intracerebral haemorrhage?A Messori, G Polonara, C Mabiglia, et al.
Anti-Cancer Drugs|January 7, 1999
Treatments for newly diagnosed advanced ovarian cancer: analysis of survival data and cost-effectiveness evaluationA Messori, S Trippoli, P Becagli, et al.
Bone Marrow Transplantation|February 1, 1994
Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation: a meta-analysisA Messori, R Rampazzo, G Scroccaro, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1997
A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanomaA Messori, P Becagli, S Trippoli, et al.
Bone Marrow Transplantation|February 1, 1997
Cost-effectiveness of autologous bone marrow transplantation in patients with relapsed non-Hodgkin's lymphomaA Messori, L Bonistalli, M Costantini, et al.
Pageof 47